$29.74
0.943.26%
After Hours: 9:28 AM EDT
15 minutes delayed
Comments
Loading...
Spyre Therapeutics
SYRENASDAQ
Spyre Therapeutics (SYRE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSpyre Therapeutics (NASDAQ:SYRE) Stock Quotes, Forecast and News Summary
Spyre Therapeutics Stock (NASDAQ: SYRE) stock price, news, charts, stock research, profile.
| Open | $29.95 |
| Close | - |
| Volume / Avg. | 568.78K / 601.65K |
| Day Range | 29.78 - 31.14 |
| 52 Wk Range | 10.42 - 47.97 |
| Market Cap | $1.56B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 58 |
| Short Interest | 18.56% |
| Days to Cover | 4.3 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Spyre Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflamm...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Spyre Therapeutics (SYRE) stock?
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Who are Spyre Therapeutics (SYRE) competitors?
Other companies in Spyre Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for Spyre Therapeutics (SYRE) stock?
There is no analysis for Spyre Therapeutics.
What is the forecast for Spyre Therapeutics (SYRE) stock?
Spyre Therapeutics has a consensus price target of $43.17.
Current stock price for Spyre Therapeutics (SYRE)?
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $29.74 last updated Today at July 16, 2024 at 9:28 AM EDT.
Does Spyre Therapeutics (SYRE) pay a dividend?
There are no upcoming dividends for Spyre Therapeutics.
When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?
Spyre Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
Is Spyre Therapeutics (SYRE) going to split?
There is no upcoming split for Spyre Therapeutics.
What sector and industry does Spyre Therapeutics (SYRE) operate in?
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.